Publication date: Oct 10, 2024
Currently, only little data is available on the impact of the COVID-19 pandemic on inpatient dermatosurgical care in German dermatological clinics. A retrospective analysis of all dermatosurgical cases that were treated in inpatient setting in nine German dermatological clinics in four federal states in 2019, 2020 and 2021 was performed. The diagnoses were recorded using the ICD-10 codes. In addition, demographic data such as age, gender and the length of inpatient stay were analysed. In 2019, 2020 and 2021, a total of 10,739, 9185 and 9828 dermatosurgical inpatients were treated respectively. Thus, the reduction of inpatient dermatosurgical cases was 14. 5% in 2020 and 8. 5% in 2021 compared to 2019. Inpatient surgical treatment of melanoma decreased by 10. 1% of cases in 2020. This decrease was only 1. 4% in 2021 compared to 2019. The number of inpatient surgeries performed for benign lesions such as melanocytic nevi or viral warts reduced sharply in both pandemic years. Our data show for the first time how inpatient care for the entire spectrum of dermatosurgical diseases developed during the COVID-19 pandemic in Germany. After the initial marked decline in inpatient dermatosurgical cases in 2020, there was less difference in 2021 compared to 2019. This trend can be interpreted as an indication that there is still a strong need for inpatient dermatosurgical care that cannot yet be met on an outpatient basis.
Concepts | Keywords |
---|---|
10codes | Care situation |
Dermatosurgical | Demographic analysis |
Germany | Long-term effect |
Outpatient | Malignant melanoma |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | MESH | melanoma |
pathway | KEGG | Melanoma |
disease | MESH | melanocytic nevi |
disease | MESH | warts |
drug | DRUGBANK | Methionine |